FBLG · FibroBiologics, Inc. · Share Buybacks
$0.92
-0.02 (-2.56%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Jul 31, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern for one year from the issuance of the condensed consolidated financial statements. While management has implemented plans to obtain additional funding, these plans are not sufficient to alleviate the substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Jul 31, 2026
Market Cap
$6.29M
Shares
6.66M
Volume · Oct 20
93.32K
Avg daily vol (3M)
209.17K
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Remaining Authorization
25,481 shares
as of 2024-12-19
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2026-05-01 | — | $6,150,000 | — | — | 8-K , filed 2026-05-01 |